Wed, December 15, 2021
Tue, December 14, 2021
Mon, December 13, 2021
Sun, December 12, 2021
Fri, December 10, 2021
Thu, December 9, 2021
Wed, December 8, 2021
Tue, December 7, 2021
Mon, December 6, 2021
Sat, December 4, 2021
Fri, December 3, 2021

Jason Butler Maintained (ACAD) at Buy with Increased Target to $39 on, Dec 9th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-39-on-dec-9th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Jason Butler of JMP Securities, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $35 to $39 on, Dec 9th, 2021.

Jason has made no other calls on ACAD in the last 4 months.



There are 5 other peers that have a rating on ACAD. Out of the 5 peers that are also analyzing ACAD, 4 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Salveen Richter of "Goldman Sachs" Maintained at Hold with Increased Target to $28 on, Wednesday, December 8th, 2021
  • Vamil Divan of "Mizuho" Maintained at Hold with Increased Target to $26 on, Tuesday, December 7th, 2021
  • Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Increased Target to $24 on, Tuesday, December 7th, 2021
  • Neena Bitritto-Garg of "Citigroup" Maintained at Hold with Increased Target to $28 on, Tuesday, December 7th, 2021


This is the rating of the analyst that currently disagrees with Jason


  • Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $23 on, Monday, November 1st, 2021

Publication Contributing Sources